Cladribine repurposed in multiple sclerosis: Making a fortune out of a generic drug

Hans J.C. Buiter, Luc Derijks, Chris J.J. Mulder

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)246-247
Number of pages2
JournalEuropean Journal of Hospital Pharmacy
Volume26
Issue number5
DOIs
Publication statusPublished - 1 Sept 2019

Keywords

  • DMT
  • Purine nucleoside analogues
  • cladribine
  • cost
  • drug
  • immune suppression
  • multiple sclerosis
  • off-label
  • re-discovery
  • subcutaneous

Cite this